✦ LIBER ✦

Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: Feasibility and potential benefits in a retrospective series of 117 patients

✍ Scribed by Bachet, J.-B.; Mitry, E.; Lièvre, A.; Lepère, C.; Vaillant, J.-N.; Declety, G.; Parlier, H.; Emile, J.-F.; Julié, C.; Rougier, P.

Book ID: 122847815
Publisher: Masson Editeur
Year: 2009
Tongue: French
Weight: 266 KB
Volume: 33
Category: Article
ISSN: 0399-8320
DOI: 10.1016/j.gcb.2009.03.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter analysis of GTX chemothera

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma

✍ Ana De Jesus-Acosta; George R. Oliver; Amanda Blackford; Katharine Kinsman; Edna 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 361 KB

Results of a retrospective analysis of g

Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer

✍ Koichi Taira; Narikazu Boku; Akira Fukutomi; Yusuke Onozawa; Shuichi Hironaka; T 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 242 KB

Second-line chemotherapy with fluorourac

Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy : A multicenter AGEO study

✍ Aziz Zaanan; Mélanie Gauthier; David Malka; Christophe Locher; Jean-Marc Gornet; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

## Abstract ## BACKGROUND: Small bowel adenocarcinoma (SBA) is a rare tumor with poor prognosis. First‐line platinum‐based chemotherapy is active in patients with advanced SBA, but data regarding second‐line chemotherapy are lacking. The aim of this study was to evaluate the efficacy and tolerabil

O3 Efficacy of second and third-line che

O3 Efficacy of second and third-line chemotherapy in patients with advanced transitional-cell carcinoma: Results of a national multicentre pooled analysis

✍ Marongiu, M.; Atzori, F.; Santoni, M.; Derosa, L.; Di Lorenzo, G.; Masini, C.; I 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Weekly regimen of epirubicin and paclita

Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study

✍ Antonio Rozzi; Margherita Salerno; Francesca Bordin; Ferdinando De Marco; Stefan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 316 KB

Methotrexate-paclitaxel-epirubicin-carbo

Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: A phase II study

✍ Amal Halim; Niveen Abotouk 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB